CCL16 and cancer: We identified several novel candidate genes (e.g., ICAM3, CCL16, PDE3A, and PRTN3) and showed that ICAM3 mediates cancer cell stemness as well as cancer-related inflammation via Src/PI3K/AKT signaling 18.